拉米宁-521:一种新型的病原性自身抗体的目标,用于抗质底膜疾病的抗质底膜疾病

Kate J Robson1

  • 1Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia; Department of Nephrology, Monash Health, Clayton, Victoria, Australia; Department of Nephrology, Western Health, St Albans, Victoria, Australia.

Kidney international
|November 19, 2023
PubMed
概括

非典型的抗质底膜疾病可能涉及针对拉米宁-521的抗体,而不仅仅是原IV. 研究人员证实了laminin-52121的存在.